Addex's Dipraglurant Blepharospasm Phase 2 Feasibility Clinical Study Fails To Meet Objectives
Verrica Gets CRL From FDA For VP-102 NDA For The Treatment Of Molluscum Contagiosum
UniQure Says FDA Accepts BLA For Etranacogene Dezaparvovec Under Priority Review